Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Entospletinib effectively prevents eye and skin GVHD in mice.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Tofacitinib is effective and safe for treating severe alopecia areata.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Ritlecitinib is safe and may effectively treat alopecia areata.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Epiprofin suppresses parathyroid hormone gene activity, helping regulate calcium levels and could be a treatment target for hyperparathyroidism.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.